Rotavirus vaccination in the US: a systematic review of vaccination coverage and completion

References

• Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and prevention of vaccine-preventable diseases - rotavirus. 13th. Washington D.C: Public Health Foundation; 2015. https://www.cdc.gov/vaccines/pubs/pinkbook/rota.html
   Google Scholar
• Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2009;58:1–25.
   PubMedGoogle Scholar
• Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar U. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev Vaccines. 2014;13(3):365–76. doi:10.1586/14760584.2014.877846.
   PubMed Web of Science ®Google Scholar
• Krishnarajah G, Duh MS, Korves C, Demissie K. Public health impact of complete and incomplete rotavirus vaccination among commercially and medicaid insured children in the United States. PLoS One. 2016;11(1):e0145977. doi:10.1371/journal.pone.0145977.
   PubMed Web of Science ®Google Scholar
• Ventola CL. Immunization in the United States: recommendations, barriers, and measures to improve compliance: part 1: childhood vaccinations. P T. 2016;41:426–36.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. VaxView Vaccination Coverage. [accessed 2020 Jun 9]. https://www.cdc.gov/vaccines/vaxview/index.html
   Google Scholar
• Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kang Y. Vaccination coverage among children aged 19-35 months - United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1171–77. doi:10.15585/mmwr.mm6643a3.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services - Office of Disease Prevention and Health Promotion. Healthy People 2020. [accessed 2018 Aug 24]. https://www.healthypeople.gov/2020/data-search/Search-the-Data#objid=4713
   Google Scholar
• United States (US) Food and Drug Administration. Highlights of Prescribing Information - Rotarix. [accessed 2018 Nov 20]. https://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm133539.pdf.
   Google Scholar
• United States (US) Food and Drug Administration. Highlights of Prescribing Information - RotaTeq. [accessed 2018 Aug 24]. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142288.pdf.
   Google Scholar
• Centers for Disease Control and Prevention. Immunization Schedules. [accessed 2020 Jun 9]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html.
   Google Scholar
• Aliabadi N, Wikswo ME, Tate JE, Cortese MM, Szilagyi PG, Staat MA, Weinberg GA, Halasa NB, Boom JA, Selvarangan R, et al. Factors associated with rotavirus vaccine coverage. Pediatrics. 2019;143(2):e20181824. doi:10.1542/peds.2018-1824.
   PubMed Web of Science ®Google Scholar
• Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kolasa M. National, state, and selected local area vaccination coverage among children aged 19-35 months - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(33):889–96. doi:10.15585/mmwr.mm6433a1.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months — United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(36):1171–77.
   PubMedGoogle Scholar
• Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J. 2011;30:S56–60. doi:10.1097/INF.0b013e3181fefdc0.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]: the Cochrane Collaboration. Chichester (UK): John Wiley & Sons; 2011. www.handbook.cochrane.org
   Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–49. doi:10.1016/j.jclinepi.2007.11.008.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Calnan M, Krishnarajah G, Duh MS, Haider BA, Yermakov S, Davis M, Yan S. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance. Hum Vaccin Immunother. 2016;12(5):1235–43. doi:10.1080/21645515.2015.1136041.
   PubMed Web of Science ®Google Scholar
• Eisenberg DF, Gu T, Krishnarajah G. Adherence to rotavirus vaccination quality measures in a commercially insured population. Hum Vaccin Immunother. 2013;9(2):389–97. doi:10.4161/hv.22877.
   PubMed Web of Science ®Google Scholar
• Krishnarajah G, Davis EJ, Fan Y, Standaert BA, Buikema AR. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States. Vaccine. 2012;30(24):3717–22. doi:10.1016/j.vaccine.2011.12.077.
   PubMed Web of Science ®Google Scholar
• Krishnarajah G, Landsman-Blumberg P, Eynullayeva E. Rotavirus vaccination compliance and completion in a Medicaid infant population. Vaccine. 2015;33(3):479–86. doi:10.1016/j.vaccine.2014.06.059.
   PubMed Web of Science ®Google Scholar
• Kurosky SK, Davis KL, Krishnarajah G. Completion and compliance of childhood vaccinations in the United States. Vaccine. 2016;34(3):387–94. doi:10.1016/j.vaccine.2015.11.011.
   PubMed Web of Science ®Google Scholar
• Lanes S, Quinlan SC, Mast TC, Greenland S, Holick CN. Assessing bias in administrative database studies of RotaTeq vaccine completion due to exclusion of subjects with incomplete follow-up. Emerg Themes Epidemiol. 2015;12(1):5. doi:10.1186/s12982-015-0027-6.
   PubMedGoogle Scholar
• Panozzo CA, Becker-Dreps S, Pate V, Jonsson Funk M, Stürmer T, Weber DJ, Brookhart MA. Patterns of rotavirus vaccine uptake and use in privately-insured US infants, 2006-2010. PLoS One. 2013;8(9):e73825. doi:10.1371/journal.pone.0073825.
   PubMed Web of Science ®Google Scholar
• Varan AK, Rodriguez-Lainz A, Hill HA, Elam-Evans LD, Yankey D, Li Q. Vaccination coverage disparities between foreign-born and U.S.-Born children aged 19-35 months, United States, 2010-2012. J Immigr Minor Health. 2017;19(4):779–89. doi:10.1007/s10903-016-0465-4.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Glossary - M. [accessed 2020 Jun 9]. https://www.cms.gov/apps/glossary/default.asp?Letter=M&Language=English. .
   Google Scholar
• Centers for Disease Control and Prevention. Immunization Schedules - Child & Adolescent Immunization Schedule. Notes: diphtheria, tetanus, and pertussis (DTaP) vaccination (minimum age: 6 weeks [4 years for Kinrix or Quadracel]). [accessed 2020 Jun 9]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html#note-dtap.
   Google Scholar
• Rotavirus vaccines WHO position paper: January 2013 - Recommendations. Vaccine. 2013;31(52):6170–71. doi:10.1016/j.vaccine.2013.05.037.
   PubMed Web of Science ®Google Scholar
• Gallagher KE, Kadokura E, Eckert LO, Miyake S, Mounier-Jack S, Aldea M, Ross DA, Watson-Jones D. Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review. BMC Public Health. 2016;16(1):172. doi:10.1186/s12889-016-2845-z.
   PubMedGoogle Scholar
• Tran AN, Husberg M, Bennet R, Brytting M, Carlsson P, Eriksson M, Storsaeter J, Österlin B, Johansen K. Impact on affected families and society of severe rotavirus infections in Swedish children assessed in a prospective cohort study. Infect Dis (Lond). 2018;50(5):361–71. doi:10.1080/23744235.2017.1416162.
   PubMed Web of Science ®Google Scholar
• Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. Pediatr Infect Dis J. 2013;32(3):278–83. doi:10.1097/INF.0b013e318275328f.
   PubMed Web of Science ®Google Scholar
• Thomas SL, Walker JL, Fenty J, Atkins KE, Elliot AJ, Hughes HE, Stowe J, Ladhani S, Andrews NJ. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted. Vaccine. 2017;35(4):680–86. doi:10.1016/j.vaccine.2016.11.057.
   PubMed Web of Science ®Google Scholar
• de Hoog MLA, Vesikari T, Giaquinto C, Huppertz H-I, Martinon-Torres F, Bruijning-Verhagen P. Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC). Hum Vaccin Immunother. 2018;14(4):1027–34. doi:10.1080/21645515.2017.1412019.
   PubMed Web of Science ®Google Scholar
• Valcarcel Salamanca B, Hagerup-Jenssen ME, Flem E. Uptake and timeliness of rotavirus vaccination in Norway: the first year post-introduction. Vaccine. 2016;34(39):4684–89. doi:10.1016/j.vaccine.2016.08.017.
   PubMed Web of Science ®Google Scholar
• Wilson SE, Chung H, Schwartz KL, Guttmann A, Deeks SL, Kwong JC, Crowcroft NS, Wing L, Tu K. Rotavirus vaccine coverage and factors associated with uptake using linked data: ontario, Canada. PLoS One. 2018;13(2):e0192809. doi:10.1371/journal.pone.0192809.
   PubMed Web of Science ®Google Scholar